IL-33 expression is increased in human fibrotic livers as well as in independent mouse models of liver fibrosis that are based on the administration of the toxins thioacetamide (TAA) or carbon tetrachloride (CCL4) [90,91]. This evidence concerns the gene IL33 and Hepatic fibrosis.